Activist Investor Jorey Chernett Discloses 14.12% Stake, Signals Intent for Strategic Engagement
STIM sits 82% above its 52-week low of $0.8.
Summary
Activist investor Jorey Chernett has disclosed a 14.12% stake in Neuronetics via a Schedule 13D, signaling potential engagement with management and the board to drive strategic changes.
Key Events · Ownership and Investor Activity · STIM
-
Activist Stake Disclosed
Jorey Chernett has filed an initial Schedule 13D, reporting beneficial ownership of 9,778,718 shares, representing 14.12% of Neuronetics' common stock. This filing supersedes a previous Schedule 13G, indicating a change from passive to active investment intent.
-
Significant Investment
The shares were acquired using personal funds totaling $19,557,436, based on the belief that the shares were undervalued. This represents a substantial investment relative to the company's market capitalization.
-
Intent for Strategic Engagement
Chernett explicitly stated the intention to review the investment and potentially engage with management and the Board of Directors. This includes discussions on capitalization, ownership structure, board composition, and potential business combinations or dispositions.
-
Follows Recent Buying Spree
This 13D filing formalizes the activist position after a series of significant open market purchases by Chernett throughout March, as previously reported in Form 4 filings.
Analysis · STIM · Industrial Applications And Services
Jorey Chernett, a significant investor, has filed an initial Schedule 13D, superseding a previous Schedule 13G, indicating a shift from passive to active ownership. This filing reveals a 14.12% beneficial ownership stake, acquired through personal funds totaling over $19.5 million. Chernett explicitly states the belief that Neuronetics' shares are undervalued and expresses intent to potentially engage with management and the board regarding strategic changes, including capitalization, ownership structure, and board composition. This move follows a series of substantial open market purchases by Chernett in March, as seen in recent Form 4 filings, consolidating a significant activist position.
How filings like this one have moved
In the 30 days to Sep 20, 2026, 39.1% of the 338 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.42%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, STIM was trading at $1.46 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $100.5M. The 52-week trading range was $0.80 to $4.85. This filing was assessed with positive market sentiment and an importance score of 9 out of 10.